Article Details

Price of Soliris Far Too High, as Efgartigimod's Likely Will Be: ICER

Retrieved on: 2021-10-22 23:20:05

Tags for this article:

Click the tags to see associated articles and topics

Price of Soliris Far Too High, as Efgartigimod's Likely Will Be: ICER. View article details on hiswai:

Excerpt

Developed by Alexion Pharmaceuticals (now part of AstraZeneca), Soliris has been approved to treat gMG in the U.S. and Europe since 2017.

Article found on: myastheniagravisnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up